ANVISA registration

Grifols sCD38

Registration 80134860308. ANTICORPO ANTI-DARATUMUMAB

Registration details

Registration number80134860308
Application number25351458325202412
Technical nameANTICORPO ANTI-DARATUMUMAB
Risk classII
Published on17/02/2025
ValidityIndefinite validity

Registration holder

Legal nameGRIFOLS BRASIL LTDA
CNPJ02.513.899/0001-71

Manufacturer

  • MEDION GRIFOLS DIAGNOSTICS AG SUÍÇA

Other registrations held by GRIFOLS BRASIL LTDAview all

AUTOANALISADOR PARA IMUNOHEMATOLOGIA WADIANA COMPACT

10364120050

IDENTISERA DIANA

10364120056

SERASCAN DIANA 2P

10364120059

SERASCAN DIANA 4

10364120060

SERASCAN DIANA 4P

10364120062

IDENTISERA DIANA EXTEND P

10364120064

Source: ANVISA

Source: ANVISA open data, medical device file, updated daily. The public database provides registration validity, rather than registration status: this registration may have been cancelled before its expiry date without this being shown here. Before making purchasing, import or marketing decisions, check the ANVISA search portal.

Next step

Medical device registration with ANVISA

HSC manages the process from risk classification to liaising with the regulator, in Brazil and more than 40 other countries.

Speak to a specialist